BIOMAT Database Logo BIOMAT Database Logo

Tuberculous peritonitis in patients on continuous ambulatory peritoneal dialysis. 2000

M F Lam, and S C Tang, and K N Lai

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008991 Monitoring, Physiologic The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine. Patient Monitoring,Monitoring, Physiological,Physiologic Monitoring,Monitoring, Patient,Physiological Monitoring
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D014395 Peritonitis, Tuberculous A form of PERITONITIS seen in patients with TUBERCULOSIS, characterized by lesion either as a miliary form or as a pelvic mass on the peritoneal surfaces. Most patients have ASCITES, abdominal swelling, ABDOMINAL PAIN, and other systemic symptoms such as FEVER; WEIGHT LOSS; and ANEMIA. Tuberculosis, Peritoneal

Related Publications

M F Lam, and S C Tang, and K N Lai
Tuberculous peritonitis in continuous ambulatory peritoneal dialysis.
January 1997, Nephron,
M F Lam, and S C Tang, and K N Lai
Non tuberculous mycobacterium peritonitis in continuous ambulatory peritoneal dialysis.
January 2001, Journal of nephrology,
M F Lam, and S C Tang, and K N Lai
Tuberculous peritonitis in a cohort of continuous ambulatory peritoneal dialysis patients.
January 2001, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
M F Lam, and S C Tang, and K N Lai
Tuberculous and fungal peritonitis in patients undergoing continuous ambulatory peritoneal dialysis.
June 2007, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
M F Lam, and S C Tang, and K N Lai
[Peritonitis in patients on continuous ambulatory peritoneal dialysis].
January 1996, Srpski arhiv za celokupno lekarstvo,
M F Lam, and S C Tang, and K N Lai
Peritonitis in continuous ambulatory peritoneal dialysis patients.
May 1983, American journal of kidney diseases : the official journal of the National Kidney Foundation,
M F Lam, and S C Tang, and K N Lai
Tuberculous peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis.
June 1988, Hiroshima journal of medical sciences,
M F Lam, and S C Tang, and K N Lai
Tuberculous peritonitis in a child undergoing continuous ambulatory peritoneal dialysis.
January 1994, Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui,
M F Lam, and S C Tang, and K N Lai
Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis.
September 1983, Annals of internal medicine,
M F Lam, and S C Tang, and K N Lai
Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis.
December 1998, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Copied contents to your clipboard!